Storyboard

Health Canada approves Pfizer anti-viral pill for treatment of COVID-19

Health Canada has approved Pfizer’s drug Paxlovid as a treatment for COVID-19. The drug has been shown to significantly reduce the risk of hospitalization for people provided they receive the drug within five days of their first symptoms. The treatment is green-lighted for adult patients with mild or moderate COVID-19 who are also at high risk of becoming more seriously ill.

Avatar - Healthing.ca
Curated by
Healthing.ca
    • Vaccination
    • COVID-19 Vaccines
    • Pfizer
    • Health Care (Canada)
    • Coronavirus (Canada)
Health Canada approves Pfizer anti-viral pill for treatment of COVID-19
Continue to read
6 stories in this Storyboard
    Health Canada approves Pfizer anti-viral pill for treatment of COVID-19

    Health Canada approves Pfizer anti-viral pill for treatment of COVID-19

    "Canada has ordered a million courses of the Paxlovid treatment, which has been shown to to significantly reduce the risk of hospitalization" Jan 17 …

More stories from Vaccination